Table 1. Correlations between RanBP9 and TSSC3 expression and the clinicopathological features of osteosarcoma.
RanBP9 |
TSSC3 |
|||||||
---|---|---|---|---|---|---|---|---|
Clinical characteristics | Group | n | Positive | Negative | P-valuea | Positive | Negative | P-valuea |
Age (years) | 11–20 | 34 | 27 | 7 | 0.182 | 25 | 9 | 0.407 |
21–30 | 23 | 21 | 2 | 19 | 4 | |||
≥31 | 23 | 16 | 7 | 15 | 8 | |||
Gender | Male | 53 | 41 | 12 | 0.408 | 37 | 16 | 0.262 |
Female | 27 | 23 | 4 | 22 | 5 | |||
Tumor location | Limbs | 70 | 57 | 13 | 0.398 | 54 | 16 | 0.068 |
Others | 10 | 7 | 3 | 5 | 5 | |||
Stage | I | 6 | 6 | 0 | 0.001b | 6 | 0 | 0.004b |
II | 61 | 55 | 6 | 48 | 13 | |||
III | 13 | 3 | 10 | 5 | 8 | |||
Lung metastasis | Yes | 13 | 3 | 10 | <0.001b | 5 | 8 | 0.002b |
No | 67 | 61 | 6 | 54 | 13 | |||
Local recurrence | Yes | 15 | 7 | 8 | <0.001b | 7 | 8 | 0.008b |
No | 65 | 57 | 8 | 52 | 13 | |||
Grade | Low | 6 | 6 | 0 | 0.203 | 6 | 0 | 0.129 |
High | 74 | 58 | 16 | 53 | 21 | |||
Histological type | Osteoblastic | 28 | 19 | 9 | 0.083 | 21 | 7 | 0.824 |
Fibroblastic | 4 | 3 | 1 | 3 | 1 | |||
Chondroblastic | 32 | 26 | 6 | 22 | 10 | |||
Others | 16 | 16 | 0 | 13 | 3 | |||
Tumor size | <10 cm | 65 | 52 | 13 | 1.000 | 46 | 19 | 0.207 |
≥10 cm | 15 | 12 | 3 | 13 | 2 |
Pearson's χ2 test
With significant difference